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Abstract: 8-Oxoguanine, a major oxidized base lesion formed by reactive oxygen species, 
causes G to T transversion mutations or leads to cell death in mammals if it accumulates in 
DNA. 8-Oxoguanine can originate as 8-oxo-dGTP, formed in the nucleotide pool, or by 
direct oxidation of the DNA guanine base. MTH1, also known as NUDT1, with 8-oxo-dGTP 
hydrolyzing activity, 8-oxoguanine DNA glycosylase (OGG1) an 8-oxoG DNA glycosylase, 
and MutY homolog (MUTYH) with adenine DNA glycosylase activity, minimize the 
accumulation of 8-oxoG in DNA; deficiencies in these enzymes increase spontaneous  
and induced tumorigenesis susceptibility. However, different tissue types have different 
tumorigenesis susceptibilities. These can be reversed by combined deficiencies in the 
defense systems, because cell death induced by accumulation of 8-oxoG in DNA is dependent 
on MUTYH, which can be suppressed by MTH1 and OGG1. In cancer cells encountering 
high oxidative stress levels, a high level of 8-oxo-dGTP accumulates in the nucleotide pool, 
and cells therefore express increased levels of MTH1 in order to eliminate 8-oxo-dGTP. 
Suppression of MTH1 may be an efficient strategy for killing cancer cells; however, because 
MTH1 and OGG1 protect normal tissues from oxidative-stress-induced cell death, it is 
important that MTH1 inhibition does not increase the risk of healthy tissue degeneration. 
Keywords: oxidative stress; nucleotide pool; nuclear DNA; mitochondrial DNA; MTH1; 
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OPEN ACCESS
Int. J. Mol. Sci. 2014, 15 12544 
 
 
1. Introduction 
For living organisms, maintaining the integrity of genetic information, encoded in genomic DNA, 
and transmitting it precisely from cell to cell, as well as from parents to offspring is the most 
fundamental biological function. Oxidative phosphorylation in mitochondria is the mechanism by which 
eukaryotic organisms produce energy to maintain life. However, electrons can leak from the respiratory 
chain, resulting in about 1 to 3 percent of consumed oxygen molecules that are partially reduced,  
thus generating reactive oxygen species (ROS) such as superoxide, hydrogen peroxide and hydroxyl 
radicals [1]. ROS, which are also generated as by-products of other metabolic processes, or as a 
consequence of exposure to pathogens, ionizing radiation, chemicals or other environmental factors, and 
as molecular executors of host defense [2], are so highly reactive that they can readily oxidize 
macromolecules in living cells, including lipids, proteins and nucleic acids. Thus, genomic DNA and its 
precursor nucleotides are always in danger of oxidation by ROS. 
Various oxidized bases and nucleotides are formed in DNA or nucleotide pools by ROS, and such 
oxidative lesions can cause mutations or cell death if they are not efficiently eliminated or repaired. 
Mutations may induce cancers, and cell death may be related to various degenerative diseases during 
aging [2]. 8-Oxoguanine (8-oxoG) is one of the major oxidized bases in DNA or the nucleotide pool [3] 
and is highly mutagenic because it can pair with adenine as well as cytosine in DNA (Figure 1) [4]. 
8-oxoG accumulates in both nuclear and mitochondrial DNA during aging, and is thus believed to be a 
major cause of cancer [5]. 
Figure 1. Formation of 8-oxoguanine and its altered base pairing property. (A) Oxidation of 
guanine base by reactive oxygen species (ROS) generates 8-oxoguanine; (B) 8-Oxoguanine 
(GO) forms a base pair with adenine as well as with cytosine in DNA. Modified from [6]. 
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In this review, I first summarize the defense systems that minimize 8-oxoG accumulation in cellular 
DNAs such as nuclear and mitochondrial genomes. Disruption of these defense systems tends to increase 
susceptibility to spontaneous and induced tumorigenesis in mice. However recent findings have 
revealed that tumorigenesis induced in this way can be resisted under certain conditions. Moreover, 
some defense systems are likely to be required for the survival of cancer cells and can, therefore,  
be targeted to develop new anti-cancer drugs. I will describe how 8-oxoG and the systems that defend 
against it are involved in these phenomena, based on the recent progress in this field. 
2. Formation of 8-Oxoguanine in Nucleic Acids and Its Origin and Distribution in DNA 
Among the guanine residues in various forms of nucleic acids, such as deoxyguanosine (dG), poly G, 
poly(dG–dC):poly(dG–dC) and denatured or native calf thymus DNA, the C-8 position of dG is the most 
effectively oxidized by ascorbic acid, thus generating 8-oxo-2'-deoxyguanosine (8-oxo-dG) (Figure 1A). 
The oxidation of dG is enhanced in the presence of H2O2 with an almost 15% yield [3]. The incubation  
of dGTP with H2O2 and ascorbic acid also results in the generation of 8-oxo-2'-deoxyguanosine 
triphosphate (8-oxo-dGTP) [7]. Treatment of dGTP with Fe2+–EDTA generates eight to nine times more 
8-oxoG residues in free dGTP nucleotide than in guanosine bases in double-stranded DNA [8]. It is 
likely that dGTP is highly susceptible to oxidation by ROS in vivo, thus yielding substantial levels of 
8-oxo-dGTP in the nucleotide pool. It has been reported that 8-oxo-dGTP is present in the 0.2–2 µM 
range in the mitochondrial nucleotide pools of several rat tissues under normal conditions [9]. 
8-oxoG prefers the syn-form in DNA and can pair with adenine and cytosine at equal efficiency, while 
guanine in DNA takes mostly an anti-form and pairs exclusively with cytosine (Figure 1B), thus,  
in DNA, 8-oxo-dGTP is frequently misinserted opposite template adenine as well as opposite cytosine 
by various DNA polymerases from bacteria to mammals [10,11]. Because guanine bases in DNA can be 
directly oxidized to 8-oxoG by ROS, it is intriguing as to what extent insertion of 8-oxo-dGTP into  
DNA or direct oxidation of guanine bases in DNA contribute to the steady state levels of 8-oxoG in  
human DNA. 
Using HPLC–MS/MS, we determined the contents of 8-oxo-dG in human nuclear DNA prepared 
from freshly isolated peripheral lymphocytes or from the same cell types that had been cultured in vitro. 
Approximately two to three 8-oxo-dG residues per 106 dG residues were detected, which corresponds to 
approximately 10,000 8-oxo-dG residues per single human nucleus [12]. Immunofluorescence detection 
of 8-oxo-dG in human chromosomes revealed that 8-oxo-dG is unevenly distributed in the normal 
human genome and that the distribution pattern is conserved among different individuals. Regions with a 
high frequency of recombination and single nucleotide polymorphisms are preferentially located within 
chromosomal regions that have a high density of 8-oxo-dG [12]. 
3. Defense Systems to Minimize Accumulation of 8-oxoG in Mammalian DNA 
In human and rodent cells, MTH1 (also known as NUDT1), a homolog of the Escherichia coli 
MutT protein, efficiently hydrolyzes oxidized purine nucleoside triphosphates, such as 8-oxo-dGTP,  
to the corresponding monophosphates and pyrophosphates (Figure 2) [13]. 8-oxo-dGMP is further 
converted to the nucleoside, 8-oxo-dG, thus avoiding their incorporation into DNA [14]. The human 
MTH1 gene is located on chromosome 7p22, and consists of five major exons: two alternative exon 1 
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sequences, namely exon 1a and 1b, and three contiguous exon 2 segments (exon 2a, 2b, and 2c), which 
are alternatively spliced. Thus, the MTH1 gene produces seven mRNA species that encode three 
different human MTH1 isoforms, hMTH1b (p22), hMTH1c (p21) and hMTH1d (p18) [15]. Most of  
the major form of hMTH1 (p18) is localized in the cytoplasm with about 5% in the mitochondrial  
matrix [16], suggesting that hMTH1 plays an important role in maintaining the quality of the nucleotide 
pools of both nuclear and mitochondrial genomes. 
Figure 2. Mutagenesis caused by 8-oxoguanine and mammalian defense systems. In the 
mutagenesis pathway, 8-oxoguanine (GO) accumulates in DNA, via the incorporation of 
8-oxo-dGTP from the nucleotide pool or because of direct oxidation of DNA. This increases 
the occurrence of A:T to C:G or G:C to T:A transversion mutations after two rounds of 
replication. Red line: mutagenic pathway. In the defense systems, MTH1 hydrolyzes 8-oxo-dGTP 
to 8-oxo-dGMP and pyrophosphate. 8-oxo-dGMP is further converted to nucleoside, 
8-oxodeozyguanosine (8-oxo-dG), thus avoiding their incorporation into DNA. 8-oxoG DNA 
glycosylase (OGG1) removes 8-oxoG to initiate base excision repair (BER). OGG1 
preferentially excises 8-oxoG opposite cytosine. MutY homolog (MUTYH) excises the 
adenine inserted opposite 8-oxoG in the template strand. Once cytosine is inserted opposite 
8-oxoG during the BER initiated by MUTYH, OGG1 can remove the 8-oxoG residue 
opposite cytosine. However, adenine can be reinserted opposite 8-oxoG during BER 
(dashed red line). In mammals, the mismatch repair machinery recognizes 8-oxoG opposite 
adenine in template DNA and excises the 8-oxoG containing nascent strand (green line). 
OGG1 may enhance A to C transversion if it excises 8-oxoG opposite cytosine that had been 
inserted opposite 8-oxoG paired with the adenine in the template DNA (dashed blue line). 
Blue lines: BER pathways. Modified from Ref. [6]. 
 
Int. J. Mol. Sci. 2014, 15 12547 
 
 
Once 8-oxoG has formed in DNA, 8-oxoG DNA glycosylase, encoded by the OGG1 gene, and 
identified as a homolog of Saccharomyces cerevisiae OGG1, removes this oxidized base to initiate base 
excision repair (BER). The DNA glycosylase activity of OGG1 preferentially excises 8-oxoG opposite 
cytosine (Figure 2). In addition, OGG1 also possesses a weak AP lyase activity. The human OGG1 gene 
is located on chromosome 3p25, a locus frequently lost in lung cancer [17,18]. 
There are more than seven alternatively spliced forms of OGG1 mRNA, and these have been 
classified into two types based on their last exons (type 1 with exon 7: 1a and 1b; type 2 with exon 8:  
2a to 2e). Types 1a and 2a are the major OGG1 transcripts in various human tissues, and encode 
OGG1-1a and OGG1-2a. OGG1-1a protein has a nuclear localization signal at its C-terminal end, and is 
thus located in the nucleus. Meanwhile, OGG1-2a protein, which has a unique C-terminal region 
consisting of two distinct regions, an acidic region (amino acid residues Ile345 to Asp381) and a 
hydrophobic region (the last 20 residues), is located exclusively in the mitochondria, although both share 
the N-terminal mitochondrial targeting signal [19]. 
A DNA glycosylase encoded by MUTYH, a homolog of E. coli mutY, excises the adenine inserted 
opposite 8-oxoG in the template strand (Figure 2) [20]. Once cytosine is inserted opposite 8-oxoG in 
template DNA during the BER initiated by MutY homolog (MUTYH), OGG1 can remove the 8-oxoG 
residue opposite cytosine in DNA. MUTYH thereby contributes to minimize 8-oxoG accumulation in 
DNA. MUTYH also has the ability to excise 2-hydroxyadenine (2-OH-A) incorporated opposite guanine in 
the template [21]. MUTYH has a functional proliferating cell nuclear antigen (PCNA)-binding motif [22], 
and we have shown that MUTYH repair of adenine incorporated opposite 8-oxoG in transfected plasmid 
DNA in cultured cells is dependent on this PCNA-binding motif [23]. However, we found that the 
PCNA-binding motif in MUTYH is not essential for suppressing the increased spontaneous mutation 
rate observed in Mutyh-knockout (KO) embryonic stem cells [24]. MUTYH also interacts with other 
replication-associated proteins, such as RPA and MSH2, which can also interact with PCNA, thus 
suggesting that the interactions of MUTYH with these proteins support its function [6,25]. 
The human MUTYH gene is located on the short arm of chromosome 1 between p32.1 and p34.3,  
and consists of 16 exons [26]. There are three major MUTYH transcripts in human cells, namely types  
α, β and γ. Each transcript has a different 5' sequence or first exon, and each is alternatively spliced, thus 
multiple forms of human MUTYH proteins are present in nuclei and mitochondria [21]. 
4. Altered Susceptibility to Spontaneous Mutagenesis and Carcinogenesis in Mice Deficient in 
8-oxoG Defense Systems 
In Mth1-KO mice, the incidence of spontaneous carcinogenesis in the liver and stomach, and to a 
lesser extent in the lung, was several-fold higher compared with that in wild-type mice at the age of  
18 months [27]. A 2–3-fold increase in the spontaneous mutation rate was also confirmed in Mth1-KO 
embryonic stem cells. However, increased accumulation of 8-oxo-dG was not apparent in Mth1-KO 
mice [28], probably because of efficient BER by OGG1. 
Two groups reported that Ogg1-KO mice are not cancer-prone within 50 weeks after birth  
even though increased accumulation of 8-oxo-dG in their genomic DNA was observed [29,30].  
However, observation over a longer time period revealed the spontaneous development of lung 
adenoma/carcinoma in 18-month-old Ogg1-KO mice [28]. This was associated with a several-fold 
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increased accumulation of genomic 8-oxo-dG, which is consistent with the chromosome 3p25 location 
of the human OGG1 gene, a locus frequently lost in lung cancer [17,18,31]. Interestingly, the 
accumulation of 8-oxo-dG was also confirmed in Ogg1/Mth1-double KO (DKO) mice, although no 
tumors were found in the lungs of these mice [28]. This observation suggests that MTH1 deficiency 
results in a suppression of the tumorigenesis caused by OGG1 deficiency, which I will discuss later. 
A systematic histological examination of large cohorts of mice revealed that more spontaneous 
tumors had developed in Mutyh-KO mice (72 of 121, 59.5%) than in the wild-type mice (38 of 109, 
34.9%) at the age of 18 months [32]. The increased incidence of intestinal tumors in Mutyh-KO mice 
(11 tumors in 121 mice) was statistically significant compared with the wild type (no intestinal tumors 
in 109 mice). Two adenomas and seven adenocarcinomas were observed in the small intestines, and 
two adenomas but no carcinomas were found in the colon [32]. These results provided experimental 
evidence for the association between biallelic germ-line MUTYH mutations and a recessive form of 
human hereditary colorectal adenoma and carcinoma [33,34]. 
Double-deficiency of both Mutyh and Ogg1 predispose 65.7% of mice to tumors, predominantly lung 
and ovarian tumors and lymphomas within 20 months of birth [35]. The 50% survival age in the 
Mutyh/Ogg1-DKO mice was significantly reduced to 10.3 months. Remarkably, subsequent analyses 
identified G to T mutations in 75% of the lung tumors at an activating hot spot, codon 12, of the K-ras 
oncogene, but no such mutations were seen in adjacent normal tissues. It is noteworthy that 8.6% of the 
Mutyh/Ogg1-DKO mice also exhibited adenomas/carcinomas in their gastrointestinal tracts, which were 
never observed in wild-type mice [35]. 
Recently, we established the Mth1/Ogg1/Mutyh-triple KO (TKO) mouse in the C57BL/6J 
background [36]. The TKO mice are viable and fertile, although more than 10 to 20 8-oxo-dG residues 
per 106 dG accumulated in various tissues including the gonads. The TKO mice exhibited a shorter 
lifespan (50% survival age, 57 weeks), and more than 35% of TKO mice developed various types of 
tumor distinguishable by macroscopic observation, such as Harderian gland, skin, breast, and ovarian 
tumors, or lymphoma. 
We bred the TKO mouse line from one pair (G1) and maintained it to the eighth generation (G8) by 
intra-generational mating. As the generations increased, it became difficult to obtain mice for breeding 
because of the decreased number of weaned mice. Several phenotypic variations were found among 
progeny, such as hydrocephalus, belly white spot, and anophthalmia. In cases of hydrocephalus and 
white spot, the traits were transmitted to the next generation in an autosomal dominant fashion  
with incomplete penetrance, indicating that inheritable mutations should arise in the TKO mice.  
By exome analyses covering 40.9 Mb of TKO mouse transcribed regions, 247 point mutations were 
identified and 244 (99%) of them were G to T mutations. The mutation rate was calculated to be  
2 × 10−7 mutations/base/generation [36]. This mutation rate is 18-fold higher than the basal level of  
1.1 × 10−8 mutations/base/generation, calculated from the specific locus test in the mouse [37]. In human 
trio analysis [38], the germline mutation rate was calculated to be 1.2 × 10−8 mutation/base/generation, 
and G to T transversion mutations were observed in about 9% of all mutations, indicating an 
approximate 200-fold increase in G to T mutations in the TKO mice. 
These results demonstrate that the defense systems to minimize 8-oxoG accumulation in mammalian 
DNA, consisting of MTH1, OGG1 and MUTYH, are very efficient at minimizing spontaneous 
mutagenesis in both somatic and germline cells. Moreover, accumulation of 8-oxoG in genomic DNA, 
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regardless of its origins (insertion of 8-oxo-dGTP from the nucleotide pool or direct oxidation of guanine 
in DNA), causes mostly G to T but not A to C transversion mutations. The latter are thought to be caused 
by insertion of 8-oxo-dGTP opposite adenine in template DNA because E. coli mutT deficient mutants 
exhibit highly increased numbers of A to C mutations [39]. It is likely that in mammals, the mismatch 
repair machinery recognizes 8-oxoG opposite adenine in template DNA, and thus excises 8-oxoG from 
the nascent strand (Figure 2) [40]. 
5. Altered Susceptibility to Induced Tumorigenesis in Mice Deficient in the Defense Systems 
Chronic oral administration of oxidizing reagent, potassium bromate (KBrO3), to Ogg1-KO mice 
induces significantly increased accumulation of 8-oxo-dG in kidney and liver DNA as well as G to T 
mutations [41,42]. Although the mice exhibited a more severe decrease of body weight gain compared 
with wild-type mice and some kidney malfunction, no tumors were found in kidney or other organs 
such as lung, liver, spleen, thymus, stomach and intestine [41,42]. 
In contrast, oral administration of KBrO3 to Mutyh-KO mice effectively induced G to T mutations 
and epithelial tumors in the small intestines, demonstrating the significance of MUTYH in the 
suppression of mutagenesis and tumorigenesis induced by oxidative stress [32]. Mutation analysis of 
tumor-associated genes from the intestinal tumors of Mutyh-KO mice that had been treated with KBrO3 
revealed many G to T mutations in either Apc, which is required for the ubiquitin-mediated degradation 
of β-catenin, or Ctnnb1, which encodes the β-catenin protein, a transcriptional activator functioning in 
the Wnt/β-catenin signal transduction pathway [43]. No mutation was detected in either K-ras (exon 2) 
or Trp53 (exons 5–8) [44]. 
These results suggest that disruption of the Wnt/β-catenin signal transduction pathway, which leads 
to stabilization and accumulation of β-catenin in nuclei resulting in increased expression of c-Myc and 
cyclin D1 [43], is causal to oxidative-stress-induced tumorigenesis in the small intestines of Mutyh-KO 
mice. Indeed, repeated oral administration of differentiation-inducing factor-1 (DIF-1), which is 
synthesized by Dictyostelium discoideum and suppresses the Wnt/β-catenin signaling pathway, 
markedly reduced the number and size of intestinal tumors that developed in Mutyh-KO mice following 
KBrO3 administration [45]. 
The difference in susceptibility to KBrO3-induced tumorigenesis between Mutyh-KO and Ogg1-KO 
mice strongly suggests that MUTYH has a special role(s) to suppress tumorigenesis in the 
gastrointestinal tract. This may explain the association between MUTYH-deficiency and the recessive 
form of hereditary multiple colorectal adenoma/carcinoma in humans, known as MUTYH-associated 
familial adenomatous polyposis (MAP), which has the characteristic feature of G to T transversion 
mutations in the GAA sequence context [33,34]. 
It is well known that UVB radiation increases the formation of 8-oxo-dG in the genomic DNA of 
epidermal cells. To verify the effect of chronic UVB irradiation on 8-oxoG-mediated tumorigenesis in 
epidermal cells, we irradiated wild-type, heterozygous and Ogg1-KO mice with UVB at a dose of  
2.5 kJ/m2 three times a week for 40 weeks [46]. We found that the mean number of tumors in Ogg1-KO 
mice was significantly increased in comparison to that in wild-type or heterozygous mice. The rate of 
developing malignant tumors in Ogg1-KO mice was also significantly higher than in wild-type mice. 
Moreover, the age of onset in Ogg1-KO mice for developing skin tumors was earlier than that in the 
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other genotypes [46]. Recently, p53 mutations were identified in UVB-induced tumors in both wild-type 
and Ogg1-KO mice. However, most of the p53 mutations found were G:C to A:T transitions at 
dipyrimidine sites; the number of G to T mutations caused by 8-oxoG did not increase in Ogg1-KO mice 
exposed to UVB [47]. These results indicate that UVB induces highly malignant tumors caused by  
p53 dipyrimidine mutations through the formation of cyclopyrimidine dimers. One can speculate that 
8-oxoG formed in the genomic DNA of OGG1-deficient epidermal cells by UVB increases chronic 
inflammation, thereby exacerbating the carcinogenesis potential of the pyrimidine dimers. The differences 
in susceptibility of Ogg1-KO mice to UVB and KBrO3-induced carcinogenesis suggests that genomic 
accumulation of 8-oxoG must be differently processed among epidermal cells and kidney, liver or 
gastrointestinal epithelial cells. For example, 8-oxoG in gastrointestinal epithelial cells or kidney may 
predominantly induce cell death, thus causing the severe decrease of body weight gain and kidney 
malfunction in KBrO3-treated Ogg1-KO mice, as discussed in the next section. 
6. Do the Defense Systems that Minimize 8-oxoG Accumulation in DNA Contribute to the 
Survival of Cancer Cells? 
Mth1-KO and Ogg1-KO mice exhibit an increased incidence of spontaneous tumors in liver and lung, 
respectively, accompanied by accumulation of 8-oxoG in their nuclear DNA. This demonstrates that 
MTH1 and OGG1 prevent accumulation of 8-oxoG in nuclear DNA, thereby suppressing mutagenesis 
and carcinogenesis. However, Mth1/Ogg1-DKO mice do not develop lung tumors, although 8-oxoG 
accumulates to high levels in their nuclear DNA [28]. This observation suggests that excess 
accumulation of 8-oxoG in combination with MTH1 and OGG1 deficiency may induce tumor cell death, 
thereby leading to diminished occurrence of lung tumors. Moreover, MTH1 over-expression in cultured 
cells [48,49] or MTH1-transgenic mice [50] creates significant resistance to cell death induced by 
various oxidative stressors. This occurs with decreased 8-oxoG accumulation in both nuclear and 
mitochondrial DNAs, while increased accumulation of 8-oxoG in nuclear DNA and/or mitochondrial 
DNA causes cell death [51]. 
Under oxidative stress, accumulation of 8-oxoG in template DNA can be highly increased,  
and MUTYH induces futile BER cycles because an adenine can be reinserted opposite an 8-oxoG 
during BER by repair DNA polymerases such as pol β and pol κ [52]. The futile BER cycle causes 
persistent accumulation of single strand breaks (SSBs) in the nascent strand because there are many 
apurinic/apyrimidinic (AP) endonucleases or AP lyases that efficiently excise AP sites repeatedly 
generated by MUTYH (Figure 3A) [6]. Persistent accumulation of SSBs in nuclear DNA continuously 
activates poly(ADP-ribose) polymerase and causes prolonged accumulation of poly(ADP-ribose) 
polymer or depletion of nicotinamide adenine dinucleotide and ATP. Under these conditions, 
processing of mitochondrial apoptosis inducing factor and its nuclear translocation is promoted, thus 
initiating cell death (Figure 3B top). Mitochondria lack replication-coupling factors such as PCNA; 
therefore, in mitochondrial DNA, MUTYH can excise adenine opposite 8-oxoG regardless of its origin. 
Indeed the accumulation of 8-oxoG in mitochondrial DNA results in the excessive formation of SSBs in 
both DNA strands through MUTYH-initiated BER. This causes mitochondrial DNA depletion, 
resulting in mitochondrial dysfunctions, such as ATP depletion and opening of the membrane 
permeability transition pore. These lead to Ca2+ efflux from mitochondria causing activation of 
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Ca2+-dependent proteases (calpains) in the cytoplasm. Activated calpains induce lysosomal rupture and 
cell death (Figure 3B bottom) [51]. 
Figure 3. MUTYH-dependent programmed cell death triggered by accumulation of 8-oxoG 
in nuclear and mitochondrial DNA. (A) 8-oxo-dGTP generated in the nucleotide pool is a 
main source of 8-oxoG accumulated in DNA, which causes accumulation of SSBs in the 
nascent DNA strand through futile BER initiated by MUTYH. ROS, reactive oxygen 
species; Red arrows, futile BER cycle; (B) Two distinct cell death pathways induced by 
MUTYH-dependent BER. Top panel: When 8-oxoG accumulates to high levels in nuclear 
DNA, poly(ADP-ribose) polymerase (PARP) binds the SSBs generated by MUTYH-initiated 
BER. The SSBs activate PARP, thus increasing poly(ADP-ribose) polymer (PAR). Persistent 
PARP activation results in depletion of both nicotinamide adenine dinucleotide (NAD+) and 
ATP followed by nuclear translocation of apoptosis inducing factor (AIF). AIF then 
executes apoptotic cell death; Bottom panel: Accumulation of high levels of 8-oxoG in 
mitochondrial DNA causes depletion of mitochondrial DNA through MUTYH-initiated 
BER, thus causing mitochondrial dysfunction and resulting in activation of calpains, which 
in turn cause lysosomal rupture leading to cell death. Modified from [6]. 
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Based on the MUTYH-dependency of 8-oxoG induced cell death, we propose that MUTYH 
primarily suppresses tumorigenesis by inducing death of pre-mutagenic or pre-cancerous cells that, 
under oxidative stress, accumulate high levels of 8-oxoG in either nuclear or mitochondrial DNA,  
thus eliminating them from stem cell or progenitor populations. In the absence of MUTYH,  
such pre-mutagenic or pre-cancerous cells can survive and have an increased mutation rate in 
proto-oncogenes or tumor suppressor genes owing to increased 8-oxoG levels. Therefore, under 
oxidative stress, Mutyh-KO mice and MAP patients are highly susceptible to tumorigenesis [6]. 
Recently, two groups reported inhibitors of MTH1 as new anti-cancer drugs [53,54]. They showed 
that MTH1 is required for the survival of cancer cells but not normal cells, probably because increased 
oxidative stress in cancer cells causes oxidization of nucleotide precursors in the nucleotide pool and 
MTH1 is required to prevent their incorporation into DNA during replication, otherwise increased 
8-oxoG accumulation in cellular DNA causes cell death. To support this new concept, it has been 
established that cancer tissues exhibit high levels of 8-oxo-dG accumulation in DNA [55], and such cells 
also exhibit highly increased levels of MTH1 expression [56–58]. Increased levels of MTH1 mRNA in 
various cancer tissues have been confirmed by comparative gene expression profiling in cancer and 
normal tissues [59]. Moreover, Rai et al. [60] demonstrated that overexpression of MTH1 can prevent 
the oncogenic Harvey rat sarcoma viral oncogene homologue (HRAS)-induced DNA damage response 
and attendant premature senescence. Conversely, they found that loss of MTH1 preferentially induces an 
in vitro proliferation defect in tumorigenic cells overexpressing oncogenic RAS. These results indicate 
that the guanine nucleotide pool is a critical target for intracellular ROS produced by oncogenic RAS 
and that RAS-transformed cells require robust MTH1 expression to proliferate. 
7. Future Perspectives 
We recently reported that excision repair of adenine inserted opposite 8-oxoG by MUTYH triggers 
neurodegeneration under oxidative stress [61]. Mutant mice lacking MTH1 and/or OGG1 exhibit severe 
neurodegeneration, whereas mutant mice lacking MUTYH or OGG1/MUTYH are resistant to 
neurodegeneration under oxidative stress. These results indicate that OGG1 and MTH1 can protect the 
brain, while MUTYH promotes neurodegeneration [50,61–63]. 
Because of highly increased accumulation of 8-oxoG in cancer cells with increased expression  
of MTH1, suppression of MTH1 may be an efficient strategy for killing cancer cells, in which 
MUTYH-dependent cell death or other types of cell death may be involved. However, it is important not 
to cause degeneration of normal tissues by MTH1 inhibition; therefore, further experimental evaluation 
is essential. 
8. Conclusions 
8-oxoG can originate as 8-oxo-dGTP in the nucleotide pool, or by direct oxidation of guanine base in 
DNA. MTH1 with 8-oxo-dGTP hydrolyzing activity, OGG1 with 8-oxoG DNA glycosylase activity and 
MUTYH with adenine DNA glycosylase activity, minimize 8-oxoG accumulation in cellular DNAs. 
Studies on Mth1/Ogg1/Mutyh-TKO mice demonstrated that the defense systems to minimize 8-oxoG 
accumulation in cellular DNAs are very efficient at minimizing spontaneous tumorigenesis as well as 
mutagenesis. Mth1/Ogg1-DKO mice, however, exhibited decreased susceptibility to spontaneous 
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tumorigenesis in comparison to Ogg1-KO or Mth1-KO mice, thus revealing that accumulation of 
8-oxoG in cellular DNAs induces MUTYH-dependent cell death. Cancer cells are always exposed to 
high oxidative stress levels, and accumulate a high level of 8-oxo-dGTP in their nucleotide pools, and 
the cells therefore express increased levels of MTH1 in order to eliminate 8-oxo-dGTP, thus supporting 
the new anti-cancer strategy of MTH1 suppression. I thus conclude that deficiencies in the defense systems 
that minimize cellular levels of 8-oxoG in either cellular DNAs or nucleotide pools contribute to both 
carcinogenesis and survival of cancer cells, and that inhibitors of MTH1 can be used for cancer therapy. 
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